Laboratorios Farmaceuticos Valuation
| ROVI Stock | EUR 51.95 1.05 2.06% |
At this time, the firm appears to be overvalued. Laboratorios Farmaceuticos secures a last-minute Real Value of €48.31 per share. The latest price of the firm is €51.95. Our model forecasts the value of Laboratorios Farmaceuticos from analyzing the firm fundamentals such as Return On Equity of 0.39, current valuation of 1.93 B, and Profit Margin of 0.23 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Laboratorios Farmaceuticos' price fluctuation is very steady at this time. Calculation of the real value of Laboratorios Farmaceuticos is based on 3 months time horizon. Increasing Laboratorios Farmaceuticos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Laboratorios Farmaceuticos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Laboratorios Stock. However, Laboratorios Farmaceuticos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 51.95 | Real 48.31 | Hype 51.95 | Naive 48.51 |
The real value of Laboratorios Stock, also known as its intrinsic value, is the underlying worth of Laboratorios Farmaceuticos Company, which is reflected in its stock price. It is based on Laboratorios Farmaceuticos' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Laboratorios Farmaceuticos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Laboratorios Farmaceuticos ROVI helps investors to forecast how Laboratorios stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Laboratorios Farmaceuticos more accurately as focusing exclusively on Laboratorios Farmaceuticos' fundamentals will not take into account other important factors: Laboratorios Farmaceuticos Total Value Analysis
Laboratorios Farmaceuticos ROVI is at this time forecasted to have takeover price of 1.93 B with market capitalization of 2.1 B, debt of 52.52 M, and cash on hands of 126.82 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Laboratorios Farmaceuticos fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.93 B | 2.1 B | 52.52 M | 126.82 M |
Laboratorios Farmaceuticos Investor Information
About 60.0% of the company outstanding shares are owned by corporate insiders. The book value of Laboratorios Farmaceuticos was at this time reported as 8.28. The company last dividend was issued on the 5th of July 2022. Based on the key indicators related to Laboratorios Farmaceuticos' liquidity, profitability, solvency, and operating efficiency, Laboratorios Farmaceuticos ROVI is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Laboratorios Farmaceuticos Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Laboratorios Farmaceuticos has an asset utilization ratio of 88.54 percent. This indicates that the Company is making €0.89 for each dollar of assets. An increasing asset utilization means that Laboratorios Farmaceuticos ROVI is more efficient with each dollar of assets it utilizes for everyday operations.Laboratorios Farmaceuticos Ownership Allocation
Laboratorios Farmaceuticos maintains a total of 51.32 Million outstanding shares. Laboratorios Farmaceuticos ROVI secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.25 % of Laboratorios Farmaceuticos ROVI outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Laboratorios Farmaceuticos Profitability Analysis
The company reported the revenue of 648.68 M. Net Income was 182.63 M with profit before overhead, payroll, taxes, and interest of 379.83 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Laboratorios Farmaceuticos' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Laboratorios Farmaceuticos and how it compares across the competition.
About Laboratorios Farmaceuticos Valuation
The stock valuation mechanism determines Laboratorios Farmaceuticos' current worth on a weekly basis. Our valuation model uses a comparative analysis of Laboratorios Farmaceuticos. We calculate exposure to Laboratorios Farmaceuticos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Laboratorios Farmaceuticos's related companies.Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. LABORATORIOS FARMACEUTICOS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1499 people.
8 Steps to conduct Laboratorios Farmaceuticos' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Laboratorios Farmaceuticos' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Laboratorios Farmaceuticos' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Laboratorios Farmaceuticos' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Laboratorios Farmaceuticos' revenue streams: Identify Laboratorios Farmaceuticos' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Laboratorios Farmaceuticos' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Laboratorios Farmaceuticos' growth potential: Evaluate Laboratorios Farmaceuticos' management, business model, and growth potential.
- Determine Laboratorios Farmaceuticos' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Laboratorios Farmaceuticos' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |